Back to Opioid Epidemic: From Evidence to Impact
Johns Hopkins University

Opioid Epidemic: From Evidence to Impact

While prescription opioids serve an invaluable role for the treatment of cancer pain and pain at the end of life, their overuse for acute and chronic non-cancer pain as well as the increasing availability of heroin and illicit fentanyl, have contributed to the highest rates of overdose and opioid addiction in U.S. history. Evidence-informed solutions are urgently needed to address these issues and to promote high-quality care for those with pain. This course and the report it is based on are a response to that need. They offer timely information and a path forward for all who are committed to addressing injuries and deaths associated with opioids in the United States.

Status: Public Health and Disease Prevention
Status: Community Health
BeginnerCourse7 hours

Featured reviews

AA

Reviewed Aug 23, 2022

This course was very helpful in understanding the extent of the problem and the kind of solutions that can be there. It will help me to look at the issue in a different light.

FG

Reviewed Feb 24, 2020

Excellent course with really key figures presenting the research and collaborative work in this evolving epidemic ty to all

IA

Reviewed May 22, 2020

Amazing course! I have learned so much from the wide array of lecturers and I am now planning on specialising on this subject through my MPH next year

CS

Reviewed Jun 14, 2022

G​ood, informative course that taught me a lot on the opioid epidemic and the ways to help combat this overbearing issue.

KR

Reviewed Mar 13, 2023

A wealth of information. I enjoyed this course and would be very interested in taking similar courses.

All reviews

Showing: 16 of 16

Libby
5.0
Reviewed Mar 16, 2022
Fadi
5.0
Reviewed Feb 24, 2020
Jilann
5.0
Reviewed Oct 14, 2022
Saul
5.0
Reviewed Jul 5, 2023
Arshdeep
5.0
Reviewed Aug 24, 2022
Isabelle-Maria
5.0
Reviewed May 23, 2020
Cooper
5.0
Reviewed Jun 15, 2022
Kimberly
5.0
Reviewed Mar 14, 2023
craig
5.0
Reviewed Feb 4, 2022
Goliyad
5.0
Reviewed Feb 6, 2024
Jp
5.0
Reviewed Mar 10, 2021
Mfon
5.0
Reviewed Sep 23, 2020
Stephanie
3.0
Reviewed Apr 6, 2020
James
3.0
Reviewed Dec 24, 2021
A.
3.0
Reviewed Jul 1, 2020
Peter
1.0
Reviewed Oct 6, 2022